Stock Events

First Trust NYSE Arca Biotechnology Index Fund 

M$2,541
0
+M$0+0% Friday 13:52

Statistics

Day High
2,541
Day Low
2,541
52W High
2,794
52W Low
2,300
Volume
920
Avg. Volume
7
Mkt Cap
63.74B
P/E Ratio
40.51
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FBT.MX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
iShares Biotechnology
IBB
Mkt Cap7.41B
iShares Nasdaq Biotechnology ETF is a direct competitor, focusing on biotechnology and pharmaceuticals, similar to FBT, with a broad exposure to these sectors.
SPDR Biotech
XBI
Mkt Cap7.19B
SPDR S&P Biotech ETF offers exposure to the biotech sector, directly competing with FBT by investing in biotechnology companies.
VanEck Biotech
BBH
Mkt Cap433.07M
VanEck Vectors Biotech ETF is a competitor because it also targets the biotechnology industry, offering similar exposure to companies in the biotech sector.
Invesco Biotechnology & Genome
PBE
Mkt Cap257.31M
Invesco Dynamic Biotechnology & Genome ETF competes by investing in biotech and genome companies, similar to FBT's focus on the biotech industry.
Virtus LifeSci Biotech Products
BBP
Mkt Cap20.68M
Virtus LifeSci Biotech Products ETF is a competitor as it focuses on biotechnology product companies, closely aligning with FBT's investment strategy.
Principal Healthcare Innovators
BTEC
Mkt Cap16.4M
Principal Healthcare Innovators Index ETF competes by focusing on small and mid-cap companies in the healthcare sector, including biotech, similar to FBT's market focus.
ALPS Medical Breakthroughs
SBIO
Mkt Cap104.11M
ALPS Medical Breakthroughs ETF is a competitor because it invests in small and mid-cap biotechnology and pharmaceutical companies, similar to FBT's investment approach.
Fortress Biotech
FBIO
Mkt Cap34.9M
Franklin Genomic Advancements ETF competes by focusing on companies involved in genomics and biotechnology, offering a similar thematic investment to FBT.
Global X Genomics & Biotechnology
GNOM
Mkt Cap95.21M
Global X Genomics & Biotechnology ETF is a competitor as it focuses on the genomics industry, overlapping with FBT's biotech investment theme.
iShares Genomics Immunology and Healthcare
IDNA
Mkt Cap135.25M
iShares Genomics Immunology and Healthcare ETF competes by investing in companies that could benefit from the long-term growth and innovation in genomics, immunology, and biotechnology, similar to FBT's focus.

About

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
Show more...
CEO
ISIN
US33733E2037

Listings